Advanced Wound Care
with Nexodyn® AOS

Wound Cleansers:
a Growing Category in a Growing Market

Advanced wound care is a fast growing market mainly composed of 4 main categories: dressings, wound cleansers, negative pressure wound therapy devices and biologics.

The global market value was $9,4 bn in 2015 and it is expected to reach $13,1 bn in 2022, with a compound annual growth rate (CAGR) of 4,7 %¹.

Among the leading categories of advanced wound care, wound cleansers are expected to attain $2,1bn in 2023, growing at a CAGR of 5,4%¹ from 2016 to 2023. The main drivers of this growth are the aging population and the increased prevalence of chronic diseases, such as diabetes.

Non-Healing Wounds: a Challenge for Patients and Society

It is estimated that 1 % to 2 % of the population will experience a chronic wound during their lifetime in developed countries² and this rate is increasing year after year. Stalled wounds may persist for months, even years^3,4 before healing.

Due to this situation, non-healing wounds represent an economic burden for health services and patients. In 2015 only, chronic wounds represented a global expenditure of $143 bn.

Stalled wounds also have a psychological and social impact on patients: infection, delays in wound healing and wound associated pain strongly affect patients' life.

For these reasons, reducing healing time and pain for patients has become a priority.

Our Solution to an Unmet Medical Need

Historically, wound cleansers were used solely to remove contaminants, foreign debris and exudate or for irrigation. In recent years, Wound Bed Preparation (WBP) is the emerging evidence-based approach that has been developed to promote healing of non-healing wounds.

The WBP approach is internationally recognized by the major wound care associations.

According to this, wound cleansers may actually play a crucial role to support healing by removing local barriers to healing while minimizing harm to wound tissue.

The principal local barriers to healing are bioburden & biofilm^5,6 and high levels of proinflammatory mediators^7-8.

Presenting Nexodyn AOS - the Wound Care Solution

Until today, no available wound cleanser matched the ideal profile in terms of safety and efficacy: an evolution is needed.

Thanks to its optimal efficacy and safety, Nexodyn AOS, the Tehclo based solution, is the first wound cleanser proven to restart healing.

Find out more about Nexodyn AOS and the evolution of wound cleansing

References

Bis Research Analysis 2016. Global Advanced Wound Care Market- Analysis and forecast (2016-2022).
Gottrup F. A specialized wound-healing center concept: importance of a multidisciplinary department structure and surgical treatment facilities in the treatment of chronic wounds. Am J Surg. 2004;187(5):S38-S43. doi: 10.1016/S0002-9610(03)00303-9. [PubMed] [CrossRef]
Frykberg RG, Banks J. Challenges in the Treatment of Chronic Wounds. Advances in wound care. 2015;4(9):560-82.
Kirker KR, James GA. In vitro studies evaluating the effects of biofilms on wound-healing cells: a review. APMIS : acta pathologica, microbiologica, et immunologica Scandinavica. 2017;125(4):344-52.
Kruse CR, The external microenvironment of healing skin wounds. Wound Repair Regen. 23(4):456-64, 2015
Leaper D, Approach to chronic wound infections. Br J Dermatol. 173 (2): 351-358, 2015
Nunan R, Cellular and molecular mechanisms of repair in acute and chronic wound healing, British Journal of Dermatology, 2014
Diegelmann RF, Excessive neutrophils characterize chronic pressure ulcers. Wound Repair Regen.11(6):490-5,2003.

Advanced Wound Carewith Nexodyn® AOS